RESTORATION ENGINE | Neurostructural–Synaptic–Network Reintegration

SCF API Equivalent: NO-API-Φ-ALZ

PCR Mode: Restorative

Biological Target Domain

Synaptic structural degeneration
Oligodendrocyte and myelin loss
Neural circuit mislearning
Large-scale network desynchronization

The Restoration Engine is activated only after successful stabilization of metabolic and immune systems.

Its role is to rebuild neural architecture and restore functional connectivity, allowing durable cognitive recovery.

This stage converts biological stabilization into functional neurological restoration.

1. SYSTEM PATHOGENESIS TARGET

Synaptic Structural Loss

energy deficit
        ↓
synaptic instability
        ↓
dendritic spine loss

Demyelination

oligodendrocyte dysfunction
        ↓
myelin sheath degradation
        ↓
slowed neural conduction

Maladaptive Neural Encoding

chronic inflammatory stress
        ↓
incorrect neural learning patterns
        ↓
cognitive rigidity

Network Desynchronization

hippocampal–cortical desynchrony
        ↓
memory encoding failure

2. FDA DRUG MAPPING

A. Neuronal Survival & Excitotoxicity Control

Drug	Mechanism	SCF Role
Memantine	NMDA receptor modulation	reduce excitotoxic neuronal damage
Acetyl-L-carnitine	mitochondrial metabolic support	neuronal survival stabilization

Justification

Excessive glutamate signaling causes excitotoxic damage to neurons.

Memantine protects neurons by:

stabilizing NMDA receptor signaling
preventing calcium overload
reducing excitotoxic injury

Acetyl-L-carnitine supports mitochondrial metabolism and neuronal energy supply.

B. Neuroplasticity Restoration

Drug	Mechanism	SCF Role
Fluoxetine	BDNF upregulation	enable neural circuit plasticity
D-cycloserine	NMDA receptor co-agonist	facilitate learning and synaptic adaptation

Justification

Neuroplasticity mechanisms are suppressed during chronic stress and inflammation.

Fluoxetine increases brain-derived neurotrophic factor (BDNF) levels, supporting:

synaptic remodeling
dendritic spine formation
adaptive learning processes

D-cycloserine enhances NMDA receptor–dependent learning pathways.

C. Remyelination Support

Drug	Mechanism	SCF Role
Clemastine fumarate	oligodendrocyte precursor activation	promote myelin regeneration

Justification

Myelin integrity is critical for efficient neural signal transmission.

Clemastine promotes:

differentiation of oligodendrocyte precursor cells
restoration of myelin sheath thickness
improved conduction velocity

D. Network Synchronization

Drug	Mechanism	SCF Role
Donepezil	acetylcholinesterase inhibition	improve cholinergic network signaling
Guanfacine	α2A adrenergic receptor agonist	stabilize prefrontal network function

Justification

Cognitive decline is associated with loss of network coherence.

Donepezil increases acetylcholine availability, enhancing:

synaptic communication
memory network synchronization

Guanfacine stabilizes prefrontal cortex signaling and improves executive network control.

3. DOSE-TIER ARCHITECTURE (SCF MODEL)

Restoration phase uses neural repair exposure tiers.

Tier	Objective
Tier 1	stabilize synaptic survival
Tier 2	activate neuroplastic repair
Tier 3	restore network coherence

Escalation only occurs after metabolic and immune stabilization has been verified.

4. ESCALATION LOGIC

Escalation permitted when

ATP markers stable
inflammatory cytokines low
sleep architecture normalized
HRV stable

Escalation blocked when

metabolic relapse detected
immune activation spike
sleep disruption
autonomic instability

5. BIOMARKER THRESHOLDS

Domain	Biomarker	Escalation Threshold
Synaptic health	BDNF levels	rising
Myelin integrity	white matter MRI markers	improving
Neurotransmission	acetylcholine activity markers	stable
Network activity	EEG gamma coherence	increasing
Cognition	episodic memory tests	improving trend

6. STOP / HOLD RULES

Restoration phase paused if:

neuroinflammation markers increase
autonomic instability detected
sleep architecture deteriorates
cognitive decline accelerates

These indicate regression to Stabilization Engine requirements.

7. RESTORATION ENGINE OUTPUT

Successful completion produces:

synaptic density restoration
myelin integrity improvement
network synchronization recovery
adaptive neuroplasticity re-engagement

This leads to durable cognitive resilience and functional stabilization.

8. FULL SCF-PCR ENGINE CASCADE

INTERCEPT ENGINE
Epigenomic stabilization
Circadian alignment
Autonomic balance

        ↓

STABILIZATION ENGINE
Mitochondrial restoration
Immune tolerance recovery
Autonomic governance stabilization

        ↓

RESTORATION ENGINE
Synaptic repair
Remyelination
Network synchronization

RESTORATION ENGINE | Neurostructural–Synaptic–Network Reintegration

SCF API Equivalent: NO-API-Φ-ALZ

PCR Mode: Restorative

Biological Target Domain

Synaptic structural degeneration
Oligodendrocyte and myelin loss
Neural circuit mislearning
Large-scale network desynchronization

The Restoration Engine is activated only after successful stabilization of metabolic and immune systems.

Its role is to rebuild neural architecture and restore functional connectivity, allowing durable cognitive recovery.

This stage converts biological stabilization into functional neurological restoration.

1. SYSTEM PATHOGENESIS TARGET

Synaptic Structural Loss

energy deficit
        ↓
synaptic instability
        ↓
dendritic spine loss

Demyelination

oligodendrocyte dysfunction
        ↓
myelin sheath degradation
        ↓
slowed neural conduction

Maladaptive Neural Encoding

chronic inflammatory stress
        ↓
incorrect neural learning patterns
        ↓
cognitive rigidity

Network Desynchronization

hippocampal–cortical desynchrony
        ↓
memory encoding failure

2. FDA DRUG MAPPING

A. Neuronal Survival & Excitotoxicity Control

Drug	Mechanism	SCF Role
Memantine	NMDA receptor modulation	reduce excitotoxic neuronal damage
Acetyl-L-carnitine	mitochondrial metabolic support	neuronal survival stabilization

Justification

Excessive glutamate signaling causes excitotoxic damage to neurons.

Memantine protects neurons by:

stabilizing NMDA receptor signaling
preventing calcium overload
reducing excitotoxic injury

Acetyl-L-carnitine supports mitochondrial metabolism and neuronal energy supply.

B. Neuroplasticity Restoration

Drug	Mechanism	SCF Role
Fluoxetine	BDNF upregulation	enable neural circuit plasticity
D-cycloserine	NMDA receptor co-agonist	facilitate learning and synaptic adaptation

Justification

Neuroplasticity mechanisms are suppressed during chronic stress and inflammation.

Fluoxetine increases brain-derived neurotrophic factor (BDNF) levels, supporting:

synaptic remodeling
dendritic spine formation
adaptive learning processes

D-cycloserine enhances NMDA receptor–dependent learning pathways.

C. Remyelination Support

Drug	Mechanism	SCF Role
Clemastine fumarate	oligodendrocyte precursor activation	promote myelin regeneration

Justification

Myelin integrity is critical for efficient neural signal transmission.

Clemastine promotes:

differentiation of oligodendrocyte precursor cells
restoration of myelin sheath thickness
improved conduction velocity

D. Network Synchronization

Drug	Mechanism	SCF Role
Donepezil	acetylcholinesterase inhibition	improve cholinergic network signaling
Guanfacine	α2A adrenergic receptor agonist	stabilize prefrontal network function

Justification

Cognitive decline is associated with loss of network coherence.

Donepezil increases acetylcholine availability, enhancing:

synaptic communication
memory network synchronization

Guanfacine stabilizes prefrontal cortex signaling and improves executive network control.

3. DOSE-TIER ARCHITECTURE (SCF MODEL)

Restoration phase uses neural repair exposure tiers.

Tier	Objective
Tier 1	stabilize synaptic survival
Tier 2	activate neuroplastic repair
Tier 3	restore network coherence

Escalation only occurs after metabolic and immune stabilization has been verified.

4. ESCALATION LOGIC

Escalation permitted when

ATP markers stable
inflammatory cytokines low
sleep architecture normalized
HRV stable

Escalation blocked when

metabolic relapse detected
immune activation spike
sleep disruption
autonomic instability

5. BIOMARKER THRESHOLDS

Domain	Biomarker	Escalation Threshold
Synaptic health	BDNF levels	rising
Myelin integrity	white matter MRI markers	improving
Neurotransmission	acetylcholine activity markers	stable
Network activity	EEG gamma coherence	increasing
Cognition	episodic memory tests	improving trend

6. STOP / HOLD RULES

Restoration phase paused if:

neuroinflammation markers increase
autonomic instability detected
sleep architecture deteriorates
cognitive decline accelerates

These indicate regression to Stabilization Engine requirements.

7. RESTORATION ENGINE OUTPUT

Successful completion produces:

synaptic density restoration
myelin integrity improvement
network synchronization recovery
adaptive neuroplasticity re-engagement

This leads to durable cognitive resilience and functional stabilization.

8. FULL SCF-PCR ENGINE CASCADE

INTERCEPT ENGINE
Epigenomic stabilization
Circadian alignment
Autonomic balance

        ↓

STABILIZATION ENGINE
Mitochondrial restoration
Immune tolerance recovery
Autonomic governance stabilization

        ↓

RESTORATION ENGINE
Synaptic repair
Remyelination
Network synchronization